Table 3 Baseline expressed circulating miRNAs that significantly correlate with extent of fatty streaks, fibrous plaques, and the number of plaques in baboon CIA after 2-year diet challenge.
From: Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions
Baseline blood miRNAs | Extent of FS | Extent of FP | Number of plaques |
|---|---|---|---|
pha-miR-30a-5p | 0.06 (− 0.36) | 0.03 (− 0.40)* | 0.06 (− 0.36) |
pha-miR-30c-5p | 0.19 (− 0.25) | 0.04 (− 0.39)* | 0.06 (− 0.35) |
pha-miR-486-5p | 0.03 (0.41)* | 0.11 (0.31) | 0.03 (0.41)* |
pha-miR-5699-5p | 0.29 (− 0.21) | 0.04 (− 0.38)* | 0.09 (− 0.32) |
pha-miR-30a-3p | 0.14 (− 0.29) | 0.01 (− 0.46)* | 0.03 (− 0.41)* |
pha-miR-3200-3p | 0.05 (− 0.29) | 0.1 (− 0.46) | 0.04 (− 0.41)* |
pha-miR-10527-57 | 0.29 (− 0.21) | 0.01 (− 0.48)* | 0.02 (− 0.42)* |
pha-miR-873-3p | 0.02 (0.43)* | 0.20 (− 0.48) | 0.04 (− 0.42)* |
pha-miR-3155a | 0.02 (0.42)* | 0.14 (0.28) | 0.02 (− 0.42)* |
pha-miR-3155b | 0.02 (0.42)* | 0.13 (0.29) | 0.02 (0.42)* |
pha-miR-30d-5p | 0.02 (− 0.43)* | 0.42 (− 0.15) | 0.38 (− 0.17) |
pha-miR-21-5p | 0.04 (− 0.26)* | 0.28 (− 0.21) | 0.33 (− 0.19) |
pha-miR-339-5p | 0.02 (− 0.42)* | 0.09 (− 0.32) | 0.14 (− 0.28) |
pha-miR-1301-3p | 0.04 (0.38)* | 0.05 (0.37) | 0.16 (0.27) |
